Vanguard Personalized Indexing Management, LLC Mereo Biopharma Group PLC Transaction History

Vanguard Personalized Indexing Management, LLC

$6.09 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 09, 2022	SELL	$0.33 - $1.69 $4,454 - $22,811	-13,498 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.04 - $1.7 $14,037 - $22,946	13,498 New	13,498 $15,000

Others Institutions Holding MREO

# of Institutions

Shares Held

107M

Call Options Held

209K

Put Options Held

479K

Rubric Capital Management LP New York, NY

15.3M
Shares

$53.6 Million
1.75% of portfolio
Janus Henderson Group PLC London, X0

12.3M
Shares

$43.2 Million
0.03% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

9.72M
Shares

$34 Million
0.07% of portfolio
Rock Springs Capital Management LP Baltimore, MD

9.53M
Shares

$33.4 Million
1.33% of portfolio
Mangrove Partners New York, NY

8.73M
Shares

$30.6 Million
4.66% of portfolio

View Full List

About Mereo Biopharma Group plc

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $437M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

More about MREO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.

Account